BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 12766598)

  • 1. Evaluation of the response to therapy of head and neck squamous cell carcinoma by using 3-[123I]iodo-L-alpha-methyl tyrosine and single photon emission tomography.
    Dierickx LO; Everaert H; Deron P; Voordeckers M; Lahoutte T; Bossuyt A
    Nucl Med Commun; 2003 Jun; 24(6):633-41. PubMed ID: 12766598
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnosis of recurrent head and neck squamous cell carcinoma with 3-[123I]iodo-L-alpha-methyltyrosine SPET.
    Dierickx LO; Lahoutte T; Deron P; Caveliers V; Vanhove C; Everaert H; Bossuyt A
    Eur J Nucl Med; 2001 Mar; 28(3):282-7. PubMed ID: 11315594
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection of tumour progression in the follow-up of irradiated low-grade astrocytomas: comparison of 3-[123I]iodo-alpha-methyl- L-tyrosine and 99mTc-MIBI SPET.
    Henze M; Mohammed A; Schlemmer H; Herfarth KK; Mier W; Eisenhut M; Debus J; Haberkorn U
    Eur J Nucl Med Mol Imaging; 2002 Nov; 29(11):1455-61. PubMed ID: 12397464
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Iodine-123 alpha-methyl-l-tyrosine single-photon emission tomography for the visualization of head and neck squamous cell carcinomas.
    Flamen P; Bernheim N; Deron P; Caveliers V; Chavatte K; Franken PR; Bossuyt A
    Eur J Nucl Med; 1998 Feb; 25(2):177-81. PubMed ID: 9473267
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of l-3-[123I]iodo-alpha-methyltyrosine SPET and [18F]fluorodeoxyglucose PET in the detection and grading of recurrences in patients pretreated for gliomas at follow-up: a comparative study with stereotactic biopsy.
    Bader JB; Samnick S; Moringlane JR; Feiden W; Schaefer A; Kremp S; Kirsch CM
    Eur J Nucl Med; 1999 Feb; 26(2):144-51. PubMed ID: 9933348
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnostic value of 123I-IMT SPECT in the follow-up of head and neck cancer.
    Plotkin M; Wurm R; Kuczer D; Wust P; Michel R; Denecke T; Ruf J; Schlenger L; Bischoff A; Felix R; Amthauer H
    Onkologie; 2006 Apr; 29(4):147-52. PubMed ID: 16601370
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 3-[123I]Iodo-alpha-methyl-L-tyrosine uptake in cerebral gliomas: relationship to histological grading and prognosis.
    Schmidt D; Gottwald U; Langen KJ; Weber F; Hertel A; Floeth F; Felsberg J; Reifenberger G; Coenen HH; Müller-Gärtner HW
    Eur J Nucl Med; 2001 Jul; 28(7):855-61. PubMed ID: 11504082
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pretreatment evaluation of carcinomas of the hypopharynx and larynx with 18F-fluorodeoxyglucose, 123I-alpha-methyl-L-tyrosine and 99mTc-hexakis-2-methoxyisobutylisonitrile.
    Henze M; Mohammed A; Mier W; Rudat V; Dietz A; Nollert J; Eisenhut M; Haberkorn U
    Eur J Nucl Med Mol Imaging; 2002 Mar; 29(3):324-30. PubMed ID: 12002706
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment of clinical usefulness of 131I alpha-methyl-tyrosine and fused SPECT/MRI imaging for diagnostics of recurrent cerebral gliomas.
    Górska-Chrzastek M; Grzelak P; Bieńkiewicz M; Tybor K; Zakrzewska E; Mikołajczak R; Stefańczyk L; Kuśmierek J
    Nucl Med Rev Cent East Eur; 2004; 7(2):135-41. PubMed ID: 15968600
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical value of iodine-123-alpha-methyl-L-tyrosine single-photon emission tomography in the differential diagnosis of recurrent brain tumor in patients pretreated for glioma at follow-up.
    Samnick S; Bader JB; Hellwig D; Moringlane JR; Alexander C; Romeike BF; Feiden W; Kirsch CM
    J Clin Oncol; 2002 Jan; 20(2):396-404. PubMed ID: 11786566
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High uptake of L-3-[123I]iodo-alpha-methyl tyrosine in pilocytic astrocytomas.
    Weckesser M; Matheja P; Rickert CH; Sträter R; Palkovic S; Löttgen J; Kurlemann G; Paulus W; Wassmann H; Schober O
    Eur J Nucl Med; 2001 Mar; 28(3):273-81. PubMed ID: 11315593
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Non-invasive grading of primary brain tumours: results of a comparative study between SPET with 123I-alpha-methyl tyrosine and PET with 18F-deoxyglucose.
    Woesler B; Kuwert T; Morgenroth C; Matheja P; Palkovic S; Schäfers M; Vollet B; Schäfers K; Lerch H; Brandau W; Samnick S; Wassmann H; Schober O
    Eur J Nucl Med; 1997 Apr; 24(4):428-34. PubMed ID: 9096095
    [TBL] [Abstract][Full Text] [Related]  

  • 13. L-3-[123I]iodo-alpha-methyl-tyrosine SPECT in non-small cell lung cancer: preliminary observations.
    Jager PL; Groen HJ; van der Leest A; van Putten JW; Pieterman RM; de Vries EG; Piers DA
    J Nucl Med; 2001 Apr; 42(4):579-85. PubMed ID: 11337545
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of 201 Tl- with 67 Ga single photon emission tomography in the diagnosis of head and neck cancer recurrence.
    Yamamoto Y; Nishiyama Y; Toyama Y; Ohbayashi Y; Iwasaki A; Satoh K; Ohkawa M
    Nucl Med Commun; 2002 Feb; 23(2):187-91. PubMed ID: 11891475
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of thallium-201 SPET and CT/MRI in the detection of residual/recurrent squamous cell carcinoma of the oral cavity.
    Lee JK; Tyan YS; Huang WS
    Eur J Nucl Med Mol Imaging; 2004 Apr; 31(4):528-31. PubMed ID: 14722682
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 123I-IMT SPECT and 1H MR-spectroscopy at 3.0 T in the differential diagnosis of recurrent or residual gliomas: a comparative study.
    Plotkin M; Eisenacher J; Bruhn H; Wurm R; Michel R; Stockhammer F; Feussner A; Dudeck O; Wust P; Felix R; Amthauer H
    J Neurooncol; 2004 Oct; 70(1):49-58. PubMed ID: 15527107
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Iodine-123 alpha-methyl tyrosine single-photon emission tomography of cerebral gliomas: standardised evaluation of tumour uptake and extent.
    Weckesser M; Griessmeier M; Schmidt D; Sonnenberg F; Ziemons K; Kemna L; Holschbach M; Langen K; Müller-Gärtner H
    Eur J Nucl Med; 1998 Feb; 25(2):150-6. PubMed ID: 9473263
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Value of 123I-IMT SPECT for diagnosis of recurrent non-astrocytic intracranial tumours.
    Plotkin M; Amthauer H; Eisenacher J; Wurm R; Michel R; Wust P; Stockhammer F; Röttgen R; Gutberlet M; Ruf J; Felix R
    Neuroradiology; 2005 Jan; 47(1):18-26. PubMed ID: 15630586
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of SPET and PET in monitoring tumour response to therapy.
    Giannopoulou C
    Eur J Nucl Med Mol Imaging; 2003 Aug; 30(8):1173-200. PubMed ID: 12811421
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comparative study of technetium-99m sestamibi and technetium-99m tetrofosmin single-photon tomography in the detection of nasopharyngeal carcinoma.
    Kostakoglu L; Uysal U; Ozyar E; Demirkazik FB; Hayran M; Atahan L; Bekdik CF
    Eur J Nucl Med; 1997 Jun; 24(6):621-8. PubMed ID: 9169568
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.